Anna Jelińska

1.5k total citations
106 papers, 1.2k citations indexed

About

Anna Jelińska is a scholar working on Pharmacology, Analytical Chemistry and Molecular Biology. According to data from OpenAlex, Anna Jelińska has authored 106 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pharmacology, 33 papers in Analytical Chemistry and 18 papers in Molecular Biology. Recurrent topics in Anna Jelińska's work include Antibiotics Pharmacokinetics and Efficacy (35 papers), Analytical Methods in Pharmaceuticals (31 papers) and Analytical Chemistry and Chromatography (16 papers). Anna Jelińska is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (35 papers), Analytical Methods in Pharmaceuticals (31 papers) and Analytical Chemistry and Chromatography (16 papers). Anna Jelińska collaborates with scholars based in Poland, Russia and United States. Anna Jelińska's co-authors include Judyta Cielecka‐Piontek, Maciej Stawny, Katarzyna Dettlaff, Przemysław Zalewski, Aleksandra Gostyńska, Magdalena Ogrodowczyk, Irena Oszczapowicz, Dariusz T. Młynarczyk, Jerzy Jankun and Tomasz Gośliński and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Anna Jelińska

100 papers receiving 1.2k citations

Peers

Anna Jelińska

PHARM

Georgia Valsami Greece

Gholamreza Bahrami Iran

Tejal Gandhi India

Andreas Sebastian Loureiro Mendez Brazil

Fahad I. Al‐Jenoobi Saudi Arabia

Abdullah M. Al‐Mohizea Saudi Arabia

Soo Kyung Bae South Korea

Alfred Tonelli United States

Mushir Ali India

Weifeng Zhu China

Georgia Valsami Greece

Anna Jelińska

272 ×0.7

PHARM

224 ×0.9

596 ×2.5

88 ×0.4

161 ×1.1

Citations per year, relative to Anna Jelińska Anna Jelińska (= 1×) peers Georgia Valsami

Countries citing papers authored by Anna Jelińska

Since Specialization

Citations

This map shows the geographic impact of Anna Jelińska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Jelińska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Jelińska more than expected).

Fields of papers citing papers by Anna Jelińska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Jelińska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Jelińska. The network helps show where Anna Jelińska may publish in the future.

Co-authorship network of co-authors of Anna Jelińska

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Jelińska. A scholar is included among the top collaborators of Anna Jelińska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Jelińska. Anna Jelińska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jadach, Barbara, Aleksandra Majchrzak‐Celińska, Violetta Krajka‐Kuźniak, et al.. (2025). Anticancer Potential of Fisetin Against Glioblastoma: In Vitro Evaluation, Radiostability Assessment, and Preliminary PLGA Encapsulation. Polymers. 17(22). 3074–3074.

Jelińska, Anna, et al.. (2025). Novel Intravenous Nanoemulsions Based on Cannabidiol-Enriched Hemp Oil—Development and Validation of an HPLC-DAD Method for Cannabidiol Determination. Molecules. 30(2). 278–278. 2 indexed citations

Jelińska, Anna, et al.. (2024). Potential Use of Common Administration of Emulsion for Parenteral Nutrition and Vinpocetine: Compatibility Study and Prospect. Metabolites. 14(8). 439–439. 1 indexed citations

Młynarczyk, Dariusz T., et al.. (2024). Curcumin Derivatives in Medicinal Chemistry: Potential Applications in Cancer Treatment. Molecules. 29(22). 5321–5321. 15 indexed citations

Dettlaff, Katarzyna, et al.. (2024). Compatibility studies of selected multichamber bag parenteral nutrition with fluconazole. Nutrition. 123. 112417–112417. 1 indexed citations

Ogrodowczyk, Magdalena, et al.. (2023). The role of pharmaceutical analysis in ensuring the safety of drug radiation sterilization. Acta Poloniae Pharmaceutica - Drug Research. 80(2). 219–233. 1 indexed citations

Jelińska, Anna, et al.. (2023). Antiemetic Drugs Compatibility Evaluation with Paediatric Parenteral Nutrition Admixtures. Pharmaceutics. 15(8). 2143–2143. 3 indexed citations

Florek, Ewa, Marta Napierała, Izabela Miechowicz, et al.. (2023). Evaluation of the Protective and Regenerative Properties of Commercially Available Artichoke Leaf Powder Extract on Plasma and Liver Oxidative Stress Parameters. Antioxidants. 12(10). 1846–1846. 2 indexed citations

Gostyńska, Aleksandra, Katarzyna Dettlaff, Anna Jelińska, & Maciej Stawny. (2023). Improving the Safety of Clinical Management of COVID-19 Patients Receiving Aminoglycosides and Parenteral Nutrition: Y-site Compatibility Studies. Journal of Pharmaceutical Sciences. 112(10). 2597–2603. 5 indexed citations

10.

Jelińska, Anna, et al.. (2023). Stability of furosemide and torasemide in parenteral nutrition admixture. Acta Poloniae Pharmaceutica - Drug Research. 80(2). 269–276. 1 indexed citations

11.

Pawełczyk, Anna, et al.. (2023). Novel Molecular Consortia of Cannabidiol with Nonsteroidal Anti-Inflammatory Drugs Inhibit Emerging Coronaviruses’ Entry. Pathogens. 12(7). 951–951. 2 indexed citations

12.

Młynarczyk, Dariusz T., Violetta Krajka‐Kuźniak, Aleksandra Majchrzak‐Celińska, et al.. (2022). Natural Compounds in Liposomal Nanoformulations of Potential Clinical Application in Glioblastoma. Cancers. 14(24). 6222–6222. 19 indexed citations

13.

Jelińska, Anna, et al.. (2019). Hepatitis C – New drugs and treatment prospects. European Journal of Medicinal Chemistry. 165. 225–249. 60 indexed citations

14.

Dettlaff, Katarzyna, Maciej Stawny, Magdalena Ogrodowczyk, et al.. (2017). Formulation and characterization of EGCG for the treatment of superficial bladder cancer. International Journal of Molecular Medicine. 40(2). 329–336. 21 indexed citations

15.

Stawny, Maciej, et al.. (2013). Pharmaceutical Point of View on Parenteral Nutrition. The Scientific World JOURNAL. 2013(1). 415310–415310. 24 indexed citations

16.

Jelińska, Anna, et al.. (2012). Determination of adamantane derivatives in pharmaceutical formulations by using spectrophotometric UV-Vis method. Drug Development and Industrial Pharmacy. 39(5). 657–661. 13 indexed citations

17.

Zalewski, Przemysław, et al.. (2010). Photostability of New Anticancer Agents. Journal of Pharmacy Research. 1700–1702.

18.

Oszczapowicz, Irena, Anna Jelińska, Judyta Cielecka‐Piontek, et al.. (2009). Development of validation of RP-HPLC method for determination of novel derivatives of daunorubicin. Chemia Analityczna. 54(5). 907–917. 5 indexed citations

19.

Zając, M, Judyta Cielecka‐Piontek, & Anna Jelińska. (2006). Development and validation of UV spectrophotometric and RP-HPLC methods for determination of ertapenem during stability studies. Chemia Analityczna. 51(5). 761–770. 17 indexed citations

20.

Cielecka‐Piontek, Judyta, et al.. (2006). Stability of ertapenem in aqueous solutions. Journal of Pharmaceutical and Biomedical Analysis. 43(2). 445–449. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact